Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Spina, Michele
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb 2007 - e7 p. digital
Publication Type: Clinical Trial, Phase II; Comment; Letter
1527-7755
10.1200/JCO.2006.09.0407 doi
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--therapeutic use
Disease-Free Survival
Dose-Response Relationship, Drug
Doxorubicin--therapeutic use
Drug Administration Schedule
Female
Humans
Lymphoma, AIDS-Related--diagnosis
Lymphoma, Non-Hodgkin--diagnosis
Male
Prednisone--therapeutic use
Prognosis
Rituximab
Survival Analysis
Treatment Outcome
Vincristine--therapeutic use
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb 2007 - e7 p. digital
Publication Type: Clinical Trial, Phase II; Comment; Letter
1527-7755
10.1200/JCO.2006.09.0407 doi
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--therapeutic use
Disease-Free Survival
Dose-Response Relationship, Drug
Doxorubicin--therapeutic use
Drug Administration Schedule
Female
Humans
Lymphoma, AIDS-Related--diagnosis
Lymphoma, Non-Hodgkin--diagnosis
Male
Prednisone--therapeutic use
Prognosis
Rituximab
Survival Analysis
Treatment Outcome
Vincristine--therapeutic use